Stoke Therapeutics Inc (NASDAQ:STOK)

14.33
Delayed Data
As of 4:00pm ET
 +0.18 / +1.27%
Today’s Change
9.55
Today|||52-Week Range
34.83
-40.27%
Year-to-Date

Stock Price Forecast

The 10 analysts offering 12-month price forecasts for Stoke Therapeutics Inc have a median target of 52.00, with a high estimate of 83.00 and a low estimate of 24.00. The median estimate represents a +262.88% increase from the last price of 14.33.

Analyst Recommendations

The current consensus among 11 polled investment analysts is to Buy stock in Stoke Therapeutics Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.69
Sales
$2.6M
Reporting Date
Aug 16

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -4.18%
 
 
 
 
 
 
Growthannually -17.83%
 
 
 
 
 

Sales

Growthquarterly -11.98%
 
 
 
 
 
 
Growthannually --
 
 
 
 
 
Key to the earnings and sales forecast charts.